Navigation Links
Human clinical trial of NIH-developed dengue vaccine begins
Date:8/9/2010

After more than a decade of development at the National Institutes of Health, a vaccine to prevent infection by the mosquito-borne dengue virus has begun human clinical testing. The vaccine was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) and is undergoing clinical study at the Johns Hopkins Bloomberg School of Public Health in Baltimore.

About 2.5 billion people in more than 100 countries worldwide live in areas where they are at risk of dengue infection. "This is an important milestone for NIAID's intramural scientists in the development of a model dengue vaccine, which could potentially have a major impact in preventing dengue," says NIAID Director Anthony S. Fauci, M.D. "With increasing infection rates and disease severity around the world and the discovery of dengue in parts of Florida, finding a way to prevent dengue infection is an important priority."

Dr. Fauci is co-author of a 2008 commentary in the Journal of the American Medical Association that raised awareness of dengue as an emerging infectious disease.

Dengue fever is caused by any of four related viruses DENV-1, DENV-2, DENV-3 and DENV-4 which are transmitted to humans by Aedes mosquitoes. Dengue virus is prevalent in the tropical and subtropical regions of the world and each year infects about 50 million to100 million people. It accounts for 25,000 deaths annually, most of them in children.

Most people infected with dengue virus experience no symptoms at all or only a mild fever. Others develop flu-like symptoms, headache, and joint and muscle pain. A smaller portion of those infected experience the more severe dengue hemorrhagic fever/shock syndrome (DHF/DSS), which can cause high fever, pain, bleeding, a drop in blood pressure, and, in some cases, coma or death.

There is no vaccine to prevent dengue infection or drug treatment for those who become infected. Current treatment recommendation
'/>"/>

Contact: Nalini Padmanabhan
padmanabhannm@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Actor and Humanitarian Harrison Ford Assists Operation Smiles Relief Efforts in Haiti
2. Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeants Pet Care Products, Inc.
3. Scripps Health Begins Pioneering Study of Human Tumor Sequencing in Cancer Patients
4. New drug for kidney transplant recipients effective in humans
5. Agility Consulting Partners with pan (Performance Assessment Network) to Bring Custom Private Label Assessment Capability to Human Resource Professionals and Consultants
6. Dolphins health shed light on human and ocean health
7. Dolphins could be ideal model to study human cervical cancer, UF veterinarians say
8. Dolphins May Warn of Health Risks in Humans
9. Inadequate access to opioid-based pain relief is a human rights issue for cancer patients
10. Sociologist expands US conversation on human rights
11. State of Oregon Department of Human Services Selects Netsmart Technologies for Comprehensive Behavioral Healthcare Integration Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
(Date:12/25/2014)... 2014 BambooFlooringChina.com sells many bamboo products ... flooring. Today, the company announces big discounts on ... and colors. , BambooFlooringChina.com is the world’s leader in ... is valid until Jan. 20, 2015. , The bamboo ... with a natural thread. All the bamboo strips for ...
(Date:12/25/2014)... December 25, 2014 When head lice hits ... in a frenzy to get rid of it while keeping ... in Coral Gables now have the solution right in their ... clinic location, Lice Troopers provides full spectrum head lice screening ... Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, ...
(Date:12/25/2014)... By Dennis Thompson ... -- Very sick children with complex chronic illnesses can receive ... a "medical home," with easy access to a team of ... were less likely to become seriously ill and need either ... received treatment at an enhanced medical home clinic at the ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- Overeating is common ... you eat in moderation, an expert says. "Don,t arrive ... up calories if you know you,ll be attending a party, ... Jill Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount ... better to eat healthy during the day and even to ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3
... , , INCLINE VILLAGE, Nev., ... today reported financial results for the second quarter ended June 30, 2009. ... second quarter of 2009 were $125.9 million, an 18 percent increase from ... primarily to royalty revenues driven by higher product sales of Avastin(R), and ...
... , , , HAYWARD, ... a global leader in the medical aesthetics market, today announced results for ... $27.4 million, an increase of approximately $9.5 million, or 53%, as compared ... the acquisition of Reliant Technologies, Inc. on December 23, 2008. The company ...
... , , , ... GXDX ), a specialized laboratory services provider, today reported revenues of ... $3.7 million benefit from changes in accounting estimates resulting primarily from ... increased 62.8% over revenues of $27.8 million for the comparable period ...
... 30 Nephros, Inc. (OTC Bulletin Board: NEPH), a medical ... infection control, and water purification, today reported that it has ... and warrants to purchase additional common stock for aggregate proceeds ... is pleased to have completed this financing, which was led ...
... , STEWARTVILLE, Minn., July 30 Rochester Medical ... quarter ended June 30, 2009. , , The Company reported ... quarter of last year. The Company also reported net loss of $77,000 ... $312,000 or $.02 per diluted share for the same period of last year. ...
... , , ... GPRO ) today reported financial results for the second ... and record sexually transmitted disease (STD), clinical diagnostics and total product ... the second quarter of 2009 as a good performance from our ...
Cached Medicine News:Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 2Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 3Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 4Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 5Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 6Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 7Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 8Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 9Health News:Solta Medical Reports Strong Second Quarter 2009 Results 2Health News:Solta Medical Reports Strong Second Quarter 2009 Results 3Health News:Solta Medical Reports Strong Second Quarter 2009 Results 4Health News:Solta Medical Reports Strong Second Quarter 2009 Results 5Health News:Solta Medical Reports Strong Second Quarter 2009 Results 6Health News:Solta Medical Reports Strong Second Quarter 2009 Results 7Health News:Solta Medical Reports Strong Second Quarter 2009 Results 8Health News:Solta Medical Reports Strong Second Quarter 2009 Results 9Health News:Solta Medical Reports Strong Second Quarter 2009 Results 10Health News:Solta Medical Reports Strong Second Quarter 2009 Results 11Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 2Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 3Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 4Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 5Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 6Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 7Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 8Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 9Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 10Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 11Health News:Nephros, Inc. Completes $1.25 Million Private Placement 2Health News:Nephros, Inc. Completes $1.25 Million Private Placement 3Health News:Rochester Medical Reports Third Quarter Results 2Health News:Rochester Medical Reports Third Quarter Results 3Health News:Rochester Medical Reports Third Quarter Results 4Health News:Rochester Medical Reports Third Quarter Results 5Health News:Rochester Medical Reports Third Quarter Results 6
(Date:12/24/2014)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... preliminary financial results for the first quarter of ... Ended September 30, 2014 Financial Highlights: , ... in 1Q14 with gross margins improved to 52% ...
(Date:12/24/2014)... SAN DIEGO , Dec. 24, 2014 /PRNewswire/ ... the West, developing the proprietary Natural Killer (NK) ... announces that Dr. Patrick Soon-Shiong , NantWorks ... into a definitive agreement to purchase approximately $48 ... In connection with the investment, he will be ...
(Date:12/24/2014)... 23, 2014 PuraMed BioScience®, Inc., (OTC Pink: ... medicinal and healthcare products, announced it received the initial ... hemp-based, advanced headache relief product, for planned distribution to ... Colorado , Washington State , ... the MigraPure H Advanced headache relief gel formulation completed, ...
Breaking Medicine Technology:TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time....
Sonix CEP provides Emergency Medicine practitioners with high performance imaging in a compact, portable system that boots up in seconds and runs on rechargeable battery up to 30 minutes so it's alwa...
MPatch® is a topical adhesive wound dressing for the local management and control of bleeding from vascular access sites and percutaneous catheters....
O-arm combines the best features of a traditional c-arm with an intra-operative 3D scannerfor unparalleled surgical imaging....
Medicine Products: